Journal of Periodontal and Implant Science

Korean Academy of Periodontology (대한치주과학회)
권호 표지
DOI QR코드

DOI QR Code

Determination of the optimal diabetes duration for bone regeneration experiments in an alloxan-induced diabetic rabbit calvarial defect model

  • Jeong, Sang-Hun (Department of Periodontology, Gangneung-Wonju National University College of Dentistry) ;
  • Jung, Bo Hyun (Department of Anatomy, Gangneung-Wonju National University College of Dentistry) ;
  • Yoo, Ki-Yeon (Department of Anatomy, Gangneung-Wonju National University College of Dentistry) ;
  • Um, Heung-Sik (Department of Periodontology, Gangneung-Wonju National University College of Dentistry) ;
  • Chang, Beom-Seok (Department of Periodontology, Gangneung-Wonju National University College of Dentistry) ;
  • Lee, Jae-Kwan (Department of Periodontology, Gangneung-Wonju National University College of Dentistry) ;
  • Choi, Won-Youl (Research Institute for Dental Engineering, Gangneung-Wonju National University)
  • Received : 2018.10.18
  • Accepted : 2018.12.16
  • Published : 2018.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: The purpose of this study was to evaluate the optimal diabetes duration for bone regeneration experiments in an alloxan monohydrate (ALX)-induced diabetic rabbit calvarial defect model by evaluating the association between diabetes duration and bone healing capacity. Methods: Twenty-four New Zealand white rabbits were used. Twenty-two rabbits were injected with 100 mg/kg of ALX to induce experimental diabetes. These rabbits were divided into 4 groups, including a control group and groups with diabetes durations of 1 week (group 1), 2 weeks (group 2), and 4 weeks (group 3). Calvarial defects were created at 1, 2, and 4 weeks after ALX injection and in the control rabbits. Cone-beam computed tomography (CBCT) scanning was performed on the day of surgery and at 2 and 4 weeks after surgery. The rabbits were sacrificed 4 weeks after surgery, followed by histological and immunofluorescence analysis. Results: The diabetic state of all diabetic rabbits was well-maintained throughout the experiment. Reconstructed 3-dimensional CBCT imaging showed more rapid and prominent bone regeneration in the control group than in the experimental groups. Histological staining showed notable bone regeneration in the control group, in contrast to scarce bone formation in the experimental groups. The appearance and immunoreactivity of receptor activator of nuclear factor-kappa B and osteoprotegerin did not show notable differences among the groups. Conclusion: ALX administration at 100 mg/kg successfully induced experimental diabetes in rabbits. The effect of diabetes on bone healing was evident when the interval between diabetes induction and the intervention was ${\geq}1$ week.

Keywords

References

  1. Stavropoulos A, Sculean A, Bosshardt DD, Buser D, Klinge B. Pre-clinical in vivo models for the screening of bone biomaterials for oral/craniofacial indications: focus on small-animal models. Periodontol 2000 2015;68:55-65. https://doi.org/10.1111/prd.12065
  2. Kantarci A, Hasturk H, Van Dyke TE. Animal models for periodontal regeneration and peri-implant responses. Periodontol 2000 2015;68:66-82. https://doi.org/10.1111/prd.12052
  3. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183-97. https://doi.org/10.2337/diacare.20.7.1183
  4. Korean Diabetes Association. Korean diabetes fact sheet 2015 [Internet]. Seoul: Korean Diabetes Association, c2011 [cited 2016 Aug 18]. Available from: http://www.diabetes.or.kr/.
  5. Goodman WG, Hori MT. Diminished bone formation in experimental diabetes. Relationship to osteoid maturation and mineralization. Diabetes 1984;33:825-31. https://doi.org/10.2337/diab.33.9.825
  6. Nyomba BL, Verhaeghe J, Thomasset M, Lissens W, Bouillon R. Bone mineral homeostasis in spontaneously diabetic BB rats. I. Abnormal vitamin D metabolism and impaired active intestinal calcium absorption. Endocrinology 1989;124:565-72. https://doi.org/10.1210/endo-124-2-565
  7. Shires R, Teitelbaum SL, Bergfeld MA, Fallon MD, Slatopolsky E, Avioli LV. The effect of streptozotocin-induced chronic diabetes mellitus on bone and mineral homeostasis in the rat. J Lab Clin Med 1981;97:231-40.
  8. Morris HF, Ochi S, Winkler S. Implant survival in patients with type 2 diabetes: placement to 36 months. Ann Periodontol 2000;5:157-65. https://doi.org/10.1902/annals.2000.5.1.157
  9. Moy PK, Medina D, Shetty V, Aghaloo TL. Dental implant failure rates and associated risk factors. Int J Oral Maxillofac Implants 2005;20:569-77.
  10. Nevins ML, Karimbux NY, Weber HP, Giannobile WV, Fiorellini JP. Wound healing around endosseous implants in experimental diabetes. Int J Oral Maxillofac Implants 1998;13:620-9.
  11. Giglio MJ, Giannunzio G, Olmedo D, Guglielmotti MB. Histomorphometric study of bone healing around laminar implants in experimental diabetes. Implant Dent 2000;9:143-9. https://doi.org/10.1097/00008505-200009020-00006
  12. Lalla E, Lamster IB, Drury S, Fu C, Schmidt AM. Hyperglycemia, glycoxidation and receptor for advanced glycation endproducts: potential mechanisms underlying diabetic complications, including diabetes-associated periodontitis. Periodontol 2000 2000;23:50-62. https://doi.org/10.1034/j.1600-0757.2000.2230104.x
  13. Taylor GW, Burt BA, Becker MP, Genco RJ, Shlossman M, Knowler WC, et al. Non-insulin dependent diabetes mellitus and alveolar bone loss progression over 2 years. J Periodontol 1998;69:76-83. https://doi.org/10.1902/jop.1998.69.1.76
  14. Balint E, Szabo P, Marshall CF, Sprague SM. Glucose-induced inhibition of in vitro bone mineralization. Bone 2001;28:21-8. https://doi.org/10.1016/S8756-3282(00)00426-9
  15. Terada M, Inaba M, Yano Y, Hasuma T, Nishizawa Y, Morii H, et al. Growth-inhibitory effect of a high glucose concentration on osteoblast-like cells. Bone 1998;22:17-23. https://doi.org/10.1016/S8756-3282(97)00220-2
  16. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988;318:1315-21. https://doi.org/10.1056/NEJM198805193182007
  17. Santana RB, Xu L, Chase HB, Amar S, Graves DT, Trackman PC. A role for advanced glycation end products in diminished bone healing in type 1 diabetes. Diabetes 2003;52:1502-10. https://doi.org/10.2337/diabetes.52.6.1502
  18. Lalla E, Lamster IB, Schmidt AM. Enhanced interaction of advanced glycation end products with their cellular receptor RAGE: implications for the pathogenesis of accelerated periodontal disease in diabetes. Ann Periodontol 1998;3:13-9. https://doi.org/10.1902/annals.1998.3.1.13
  19. Brussee V, Guo G, Dong Y, Cheng C, Martinez JA, Smith D, et al. Distal degenerative sensory neuropathy in a long-term type 2 diabetes rat model. Diabetes 2008;57:1664-73. https://doi.org/10.2337/db07-1737
  20. Diabetes Control and Complications Trial Research GroupNathan DM, Genuth S, Lachin J, Cleary P, Crofford O, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86. https://doi.org/10.1056/NEJM199309303291401
  21. Kamiya H, Zhang W, Sima AA. Degeneration of the Golgi and neuronal loss in dorsal root ganglia in diabetic BioBreeding/Worcester rats. Diabetologia 2006;49:2763-74. https://doi.org/10.1007/s00125-006-0379-0
  22. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53. https://doi.org/10.1016/S0140-6736(98)07019-6
  23. Follak N, Kloting I, Wolf E, Merk H. Histomorphometric evaluation of the influence of the diabetic metabolic state on bone defect healing depending on the defect size in spontaneously diabetic BB/OK rats. Bone 2004;35:144-52. https://doi.org/10.1016/j.bone.2004.03.011
  24. Shyng YC, Devlin H, Sloan P. The effect of streptozotocin-induced experimental diabetes mellitus on calvarial defect healing and bone turnover in the rat. Int J Oral Maxillofac Surg 2001;30:70-4. https://doi.org/10.1054/ijom.2000.0004
  25. Lenzen S. The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia 2008;51:216-26. https://doi.org/10.1007/s00125-007-0886-7
  26. Lackey RW, Bunde CA, Gill AL, Harris LC. Glycogen in alloxan-treated rats. Proc Soc Exp Biol Med 1944;57:191-4. https://doi.org/10.3181/00379727-57-14750
  27. Zhao ZH, Watschinger B, Brown CD, Beyer MM, Friedman EA. Variations of susceptibility to alloxan induced diabetes in the rabbit. Horm Metab Res 1987;19:534-7. https://doi.org/10.1055/s-2007-1011876
  28. Nath MC, Gadgil JS, Hatwalne VG. Studies on alloxan diabetes. I. Increase of susceptibility caused by acetoacetate. Biochem J 1953;53:481-3. https://doi.org/10.1042/bj0530481
  29. Hadour G, Ferrera R, Sebbag L, Forrat R, Delaye J, de Lorgeril M. Improved myocardial tolerance to ischaemia in the diabetic rabbit. J Mol Cell Cardiol 1998;30:1869-75. https://doi.org/10.1006/jmcc.1998.0751
  30. Mah P, Reeves TE, McDavid WD. Deriving Hounsfield units using grey levels in cone beam computed tomography. Dentomaxillofac Radiol 2010;39:323-35. https://doi.org/10.1259/dmfr/19603304
  31. Greenwald JA, Mehrara BJ, Spector JA, Chin GS, Steinbrech DS, Saadeh PB, et al. Biomolecular mechanisms of calvarial bone induction: immature versus mature dura mater. Plast Reconstr Surg 2000;105:1382-92.
  32. Hsu H, Lacey DL, Dunstan CR, Solovyev I, Colombero A, Timms E, et al. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci U S A 1999;96:3540-5. https://doi.org/10.1073/pnas.96.7.3540
  33. Horowitz MC, Xi Y, Wilson K, Kacena MA. Control of osteoclastogenesis and bone resorption by members of the TNF family of receptors and ligands. Cytokine Growth Factor Rev 2001;12:9-18. https://doi.org/10.1016/S1359-6101(00)00030-7
  34. Crotti T, Smith MD, Hirsch R, Soukoulis S, Weedon H, Capone M, et al. Receptor activator NF kappaB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis. J Periodontal Res 2003;38:380-7. https://doi.org/10.1034/j.1600-0765.2003.00615.x
  35. Rees DA, Alcolado JC. Animal models of diabetes mellitus. Diabet Med 2005;22:359-70. https://doi.org/10.1111/j.1464-5491.2005.01499.x
  36. Wang J, Wan R, Mo Y, Zhang Q, Sherwood LC, Chien S. Creating a long-term diabetic rabbit model. Exp Diabetes Res 2010;2010:289614.
  37. Mir SH, Darzi MM. Histopathological abnormalities of prolonged alloxan-induced diabetes mellitus in rabbits. Int J Exp Pathol 2009;90:66-73. https://doi.org/10.1111/j.1365-2613.2008.00615.x